High Times reports a small clinical trial of an experimental medication for cannabis withdrawal. Here’s what we know now, how it could work, and what DMV patients should watch.

Virginia legalized both medical and adult-use weed. Learn about Virginia cannabis laws for possession, home grow, public use, and the timeline for recreational retail sales.

Texas spared hemp beverages in a recent crackdown, and Viola is prepping for a possible 3–5 mg federal cap. Here’s how the uncertainty could reshape delivery menus and compliance in the DMV.

California’s Q2 cannabis retail sales reached $1.013B and held steady year over year, hinting at stabilization and new lessons for delivery teams.

MJBizDaily reports roughly two-thirds of Missouri cannabis operators passed on DEA registration after federal rescheduling. Here’s what that choice could mean for compliance, delivery and the DMV.

Policy strategist Hirsh Jain joins LEEF Brands’ board as an independent director, signaling deeper focus on governance, interstate commerce, and market expansion.

New research analyzing 544,000 survey responses examines whether substance arrest rates reflect drug pharmacology or biased policing practices.

Discover the legal battles, scientific testing disputes, and regulatory developments surrounding the Church of Sacred Synthesis sacrament.

The U.S. House takes up a Senate bill delaying federal hemp THC restrictions, allowing time for congressional safety regulations.

An overview of microdosing evidence for anxiety from the Microdosing Institute and its legal context across DC, Maryland, and Virginia.

Emerging research shows Fusarium mold may be more common in cannabis than known, raising questions about current state microbial testing rules.

Learn how federal cannabis rescheduling weed delivery rules will impact DC, Maryland, and Virginia. Explore Schedule III legal timelines and delivery guidelines.